Leukocyte Separation on the Basis of their Receptors for Biogenic Amines and Prostaglandins: Relation of the Receptor to Antibody Formation

  • K. L. Melmon
  • Y. Weinstein
  • G. M. Shearer
  • H. R. Bourne


In the previous chapter (Bourne et al., 1973), the effects of biogenic amines and the E series prostaglandins on various immunologic processes were discussed. All stimulators of cyclic AMP accumulation in leukocytes appeared to inhibit at least three separate immunologic events. Histamine, beta catecholamines, and prostaglandin E1 and E2 inhibited IgE-induced release of histamine and other mediators of the inflammatory process from basophils and mast cells. The same drugs also inhibited lysis of allogeneic target cells (Henney et al., 1972) by sensitized lymphocytes, and they inhibited release of antibody from the splenic lymphocytes of mice immunized with sheep erythrocytes (Melmon et al., 1973a).


Biogenic Amine Mouse Spleen Cell Mine Receptor Physiologic Receptor Unbind Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Bourne, H. R., Melmon, K. L., Weinstein Y., and Shearer, G. M. “Pharmacologic Regulation of Antibody Release in Vitro: Effects of Vasoactive Amines and Cyclic AMP,” Proc. of Conf. on Cyclic Nucleotides, Immune Responses, and Tumor Growth (1973).Google Scholar
  2. Brody, T. “Identification of Two Cell Populations Required for Mouse Immunocompetence,” J. Immunol. 105:126 (1970).PubMedGoogle Scholar
  3. Henney, C. S., Bourne, H. R., and Lichtenstein, L. M. “The Role of Cyclic 3′,5′-Adenosine Monophosphate in the Specific Cytolytic Activity of Lymphocytes,” J. Immunol. 108:1526 (1972).PubMedGoogle Scholar
  4. Innes, I. R., and Nickersen, M. “Drugs Acting on Postganglionic Adrenergic Nerve Endings and Structures Innervated by Them (Sympathomimetic Drugs).” In The Pharmacologic Basis of Medical Practice, L. S. Goodman and A. Gilman, eds., 3rd ed. New York: MacMillan Co., p. 477 (1965).Google Scholar
  5. Jerne, W. K., Nordin, A. A., and Henney, C. “The Agar Plaque Technique for Recognizing Antibody Producing Cells.” In Cell Bound Antibodies, B. Amos and H. Koprowski, eds. Philadelphia: Wistar Institute Press, p. 109 (1963).Google Scholar
  6. Melmon, K. L., Bourne, H. R., Weinstein, Y., and Sela, M. “Receptors for Histamine Can be Detected on the Surface of Selected Leukocytes,” Science 177:707 (1972).PubMedCrossRefGoogle Scholar
  7. Melmon, K. L., Bourne, H. R., Weinstein, Y., Shearer, G. M., and Bauminger, S. “Release of Antibody from Leukocytes in Vitro: Control by Vasoactive Hormones and Cyclic AMP” (submitted for publication—1973a).Google Scholar
  8. Melmon, K. L., Weinstein, Y., Shearer, G. M., Bourne, H. R., and Bauminger, S. “Separation of Specific Antibody-Forming Mouse Spleen Cells by Their Receptors to Endogenous Hormones” (submitted for publication—1973b).Google Scholar
  9. Porath, J., Axen, R., and Ernback, S. “Chemical Coupling of Proteins to Agarose,” Nature 215:491 (1967).CrossRefGoogle Scholar
  10. Sela, M., and Fuchs, S. “Preparation of Synthetic Polypeptides As Antigens.” In Methods in Immunology and Immunochemistry, C. A. Williams and M. W. Chase, eds., vol 1. New York: Academic Press, p. 167 (1967).Google Scholar
  11. Shearer, G. M., Cudkowicz, G., Connell, M. J., and Priore, R. L. “Cellular Differentiation of the Immune System of Mice. I. Separate Splenic Antigen-Sensitive Units for Different Types of Antisheep Antibody-Forming Cells,” J. Exp. Med. 128:437 (1968).PubMedCrossRefGoogle Scholar
  12. Shearer, G. M., Melmon, K. L., Weinstein, Y., and Sela, M. “Regulation of Antibody Response By Cells Possessing Histamine Receptors,” J. Exp. Med. 136:1302 (1972).PubMedCrossRefGoogle Scholar
  13. Shearer, G. M., Weinstein, Y., Melmon, K. L., and Bourne, H. R. “Separation of Leukocytes by Their Amine Receptors: Subsequent Immunologic Functions,” Proc of Conf. on Cyclic Nucleotides, Immune Responses, and Tumor Growth (1973).Google Scholar
  14. Singhal, S. K., and Wizzell, H. “In Vitro Induction of Specific Unresponsiveness of Immunologically Reactive, Normal Bone Marrow Cells,” J. Exp. Med. 131:149 (1970).PubMedCrossRefGoogle Scholar
  15. Venter, Y. C., Dixon, Y. E., Maroko, P. R., and Kaplan, J. O. “Biologically Active Catecholamines Covalently Bound to Glass Beads,” Proc. Nat. Acad. Sci. 69:1141 (1972).PubMedCrossRefGoogle Scholar
  16. Weinstein, Y., Melmon, K. L., Bourne, H. R., and Sela, M. “Specific Leukocyte Receptors for Small Endogenous Hormones: Detection by Cell Binding to Insolubilized Hormone Preparations,” J. Clin. Invest. (in press—1973).Google Scholar
  17. Wilson, J. D. “The Relationship of Antibody-Forming Cells to Rosette-Forming Cells,” Immunol. 21:233 (1971).Google Scholar
  18. Wizzell, H., and Andersson, B. “Cell Separation on Antigen-Coated Columns,” J. Exp. Med. 129:23 (1969).CrossRefGoogle Scholar
  19. Wofsy, L., Kimura, J., and Truffa-Bachi, P. “Cell Separation on Affinity Columns: The Preparation of Pure Populations of Antihapten Specific Lymphocytes,” J. Immunol. 107:725 (1971).PubMedGoogle Scholar
  20. Wortis, H. H., Taylor, R. B., and Dresser, D. W. “Antibody Production Studied by Means of the LHG Assay. I. The Splenic Response of CBA Mice to Sheep Erythrocytes,” Immunol. 11:603 (1966).Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1974

Authors and Affiliations

  • K. L. Melmon
  • Y. Weinstein
  • G. M. Shearer
  • H. R. Bourne

There are no affiliations available

Personalised recommendations